Newsletter | December 10, 2019

12.10.19 -- Understanding Biomarkers For Better Drug Discovery And Development

 
Industry Insights
Understanding Biomarkers For Better Drug Discovery And Development
Article | By Gunjan Choudhary and Laura Moriarty, Bio-Rad Laboratories, Inc.

In collaboration with Amplion Inc., we investigated biomarker usage within 24 companies focused on immunotherapy. This article shares exciting insights from our analysis, including which biomarkers are the most popular and how those biomarkers are being utilized by each company.

Selectivity In Size Exclusion Chromatography (SEC): It’s Much More Than Average Pore Diameter (Å)
Article | By Jon Lundqvist, GE Healthcare Life Sciences

Describing the pore of a size exclusion chromatography resin with a single number such as average pore diameter is an oversimplification. The formation of pores is dependent on complex combinations of many parameters.

Meeting Patient Needs Through Expedited Delivery Of Phase I Materials
Case Study | Thermo Fisher Scientific

To quickly deliver their product to patients in need, Reneo Pharma found a partner to provide both product development and clinical packaging services.

Vertex Pharmaceuticals: Document Management Strategies For R&D
Case Study | Dassault Systemes Americas

Based out of South Boston, MA, with additional research programs in the UK and Canada, Vertex Pharmaceuticals has spent the past 25 years working to improve the lives of patients with serious diseases.

Most Popular News
Solutions
Formulation And Analytical Solutions
GVK Biosciences
Early Development Fact Sheet
Thermo Fisher Scientific
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.